About the Authors
- Ditte-Marie Bretler
-
* E-mail: dimabr01@geh.regionh.dk
Affiliation Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
- Peter Riis Hansen
-
Affiliation Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
- Jesper Lindhardsen
-
Affiliation Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
- Ole Ahlehoff
-
Affiliation Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
- Charlotte Andersson
-
Affiliation Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
- Thomas Bo Jensen
-
Affiliation Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
- Jakob Raunsø
-
Affiliations Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark, Department of Internal Medicine, Copenhagen University Hospital Holbæk, Holbæk, Denmark
- Christian Torp-Pedersen
-
Affiliations Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark, Faculty of Health Sciences, Panum Institute, University of Copenhagen, Copenhagen, Denmark
- Gunnar Hilmar Gislason
-
Affiliation Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
Competing Interests
Dr. Gislason has received a research grant from the Novo Nordisk Foundation and is owner of Novo Nordisk shares. Dr. Ahlehoff has received honoraria from Abbott and Pfizer. All other authors: No conflicting interests.
Author Contributions
Conceived and designed the experiments: DMB CTP GHG. Performed the experiments: DMB JL. Analyzed the data: DMB PRH JL OA CA TBJ JR CTP GHG. Wrote the paper: DMB. Acquisition of data: DMB CTP. Funding and supervision: DMB PRH CTP GHG. Critical revision of the manuscript: DMB PRH JL OA CA TBJ JR CTP GHG. Final approval of the submitted manuscript: DMB PRH JL OA CA TBJ JR CTP GHG.